Tanaka, Yoshiya http://orcid.org/0000-0002-0807-7139
Article History
Received: 19 May 2020
Accepted: 1 July 2020
First Online: 7 September 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Y. Tanaka has received consulting fees, speaking fees, and/or honoraria from Daiichi-Sankyo, Eli Lilly, Novartis, YL Biologics, Bristol-Myers, Eisai, Chugai, Abbvie, Astellas, Pfizer, Sanofi, Asahi-kasei, GSK, Mitsubishi-Tanabe, Gilead, and Janssen and has received research grants from Abbvie, Mitsubishi-Tanabe, Chugai, Asahi-Kasei, Eisai, Takeda, and Daiichi-Sankyo.